Speaker Profile

Ph.D., CEO, Onegevity, A division of Thorne HealthTech; Professor, Institute for Systems Biology

Dr. Nathan Price is the CEO of Onegevity, a division of Thorne HealthTech. In 2019, he was selected as one of 10 Emerging Leaders in Health and Medicine by the National Academy of Medicine.  He is also an (on leave) Professor at the Institute for Systems Biology, where he co-directs with Lee Hood the Hood-Price Lab for Systems Biomedicine.  He is Affiliate Faculty at the University of Washington and a previous co-founder of Arivale.  He is a Camille Dreyfus Teacher-Scholar, a Fellow of the American Institute for Medical and Biological Engineering, and received a 2020 Healthy Longevity Catalyst Award from the National Academy of Medicine.

 Session Abstract – PMWC 2022 Silicon Valley

Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.


Microbiome and Cancer
Jennifer Wargo, MD Anderon
Sandrine Miller-Montgomery, UCSD

The Gut/Brain Microbiome
Mary Conrad, Axial Biotherapeutics
Chris Reyes, Bloom Science
Rosa Krajmalnik-Brown, Arizona State University

The Role of the Human Gut Microbiome on Various Diseases
Colleen Cutcliffe, Pendulum Therapeutics
Tor Savidge, Baylor College of Medicine
Nikole Kimes, Siolta Therapeutics
Sarkis Mazmanian, Caltech

Pharma Drug Development
Karim Dabbagh, Second Genome
Ethan Grant, Gilead
Matthew Henn, Seres

Direct-To-Consumer Testing/Technologies
Kiran Krishnan, Microbiome Labs
Nathan Price, Onegevity
Nicole Scott, Cybele
Emmanuel Hanon, Viome

Regulatory Perspective
Scott Jackson, NIST

Synthetic Biology in Microbiome
Jeff Hasty, UCSD

AI & ML in Microbiome
Kaja Milanowska-Zabel, Ardigen